CRISPR/Cas9 Ribonucleoprotein Nucleofection for Genome Editing in Primary Human Keratinocytes: Knockouts, Deletions, and Homology‐Directed Repair Mutagenesis
Open accessAbstract
Keratinocytes are the most abundant cell type in the human epidermis, the outermost layer of the skin. For years, primary human keratinocytes (HKs) have been used as a crucial tool for studying the pathogenesis of a wide range of skin‐related diseases. To mimic the physiological and pathological behavior of human skin, organotypic 3D skin models can be generated by in vitro differentiation of HKs. However, manipulation of HKs is notoriously difficult. Liposome‐mediated gene delivery often results in low transfection rates, and conventional electroporation results in high mortality, is difficult to optimize, and requires high cell numbers without necessarily achieving maximum efficiency. Additionally, HKs have a short lifespan in vitro, with a limited number of cell divisions before senescence, even when cultured on a feeder layer. Therefore, the possibility to use an efficient CRISPR/Cas9 system in HKs is not without challenge in terms of transfection technology and clonal selection. In this article, we provide detailed protocols to perform efficient gene knock‐out (KO) or genomic deletion in a small number of HKs without clonal selection of edited cells. By nucleofecting ribonucleoprotein complexes, we efficiently generate KO cells as well as deletion of specific genomic regions. Moreover, we describe an optimized protocol for generating site‐specific mutations in immortalized keratinocytes (N/TERT2G) by exploiting the homology‐directed repair system combined with rapid single‐clone screening. These methods can also be applied to other immortalized cells and tumoral cells of epithelial origin. Together, these protocols provide a comprehensive and powerful tool that can be used to better understand the molecular mechanisms underlying different skin diseases. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Knock‐out generation by indel mutation in primary human keratinocytes using nucleofection of ribonucleoprotein (RNP) complex Basic Protocol 2: Deletion of specific genomic region using RNPs via nucleofection Basic Protocol 3: Use of homology‐directed repair system to introduce site‐specific mutations
AI snapshot
Written from the paper’s full text.
TL;DR
This protocol describes CRISPR/Cas9 ribonucleoprotein nucleofection for primary human keratinocytes to generate knockouts, genomic deletions, and homology-directed repair-mediated site-specific mutations without viral vectors. It reports high editing efficiencies in small cell numbers and provides optimized steps for feeder culture, sgRNA design, nucleofection, and clone screening.
Key findings
- RNP nucleofection with the DS138 program in primary HKs achieved >90% genome editing efficiency for knockout without clonal selection; general editing efficiencies were >80% for both KO and genomic deletion, though efficiency may vary by protein of interest.
- Two independent RNPs flanking a target region yielded up to 90% targeted genomic deletion in primary HKs in 3 days without clonal selection.
- HDR with donor oligo and HDR Enhancer V2 achieved 50% to 60% efficiency of the desired modification in immortalized N/TERT2G keratinocytes; bulk HDR analysis showed ∼40% of cells had not integrated the site-specific modification, requiring single-clone isolation.
- The best efficiency/survival ratio for primary HKs was obtained with the DS138 program; for SCC13, ED138 improved nucleofection efficiency without excessively affecting viability. Comparable editing was achieved with 1 × 10⁵ and 2 × 10⁵ cells without scaling up Cas9 and sgRNA volumes.
Methods
- Protocol paper using primary human keratinocytes cultured on mitotically inactivated 3T3-J2 feeders (or EpiLife medium), plus N/TERT2G and epithelial cancer lines; RNP complexes were assembled from Alt-R S.p. HiFi Cas9 Nuclease V3 and modified sgRNA and delivered with a Lonza Amaxa 4D-Nucleofector.
- For KO and deletion, cells were harvested ≥72 hr post-nucleofection and analyzed by western blot, PCR discriminating wild-type versus deleted amplicons, and densitometry; HDR used donor oligos, a silent restriction-site mutation for pre-screening, single-cell cloning, PCR/enzymatic digestion, and Sanger sequencing.
- Representative analyses reported in figures used n = 3 for western blot and deletion PCR, and n = 4 for HDR digestion, with two-tailed paired Student’s t-tests.
Limitations
- Stated: HDR is statistically less efficient than NHEJ and requires single-clone selection; single-cell cloning is time-consuming, requires several cell doublings, and dilution immediately after nucleofection increases cell mortality. The authors suggest isolating at least 50 to 100 clones, and the HDR protocol takes 10 to 15 days.
- Stated: primary HKs have a short in vitro lifespan with limited divisions before senescence, and editing efficiency may vary depending on the protein of interest; Cas9/sgRNA RNPs cannot be pre-annealed and stored at −80°C.
- Evident: the KO and deletion protocols use bulk populations without selection, so residual unedited cells can remain, as shown by faint protein bands and full-length PCR amplicons; the methods are optimized for specific nucleofector programs and cell types, so transferability may require further optimization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
9 of 12 cited sources checked · 3 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Antibiotic resistance-based selection methods for screening recipient cells result in low efficiency in HKs due to their short lifespan.
“Additionally, the antibiotic resistance–based selection methods associated with the screening of recipient cells results in low efficiency considering the short lifespan of HKs (Fenini et al., 2018).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fenini et al., 2018 source
In “Establishment of a protocol for stable genetic modification of keratinocytes” (page unavailable), the paper says antibiotic selection in co-culture enabled efficient modification of human primary keratinocytes, contrary to the claimed low efficiency. It notes that these cells stop proliferating after a few passages under certain culture conditions and that prolonged puromycin selection harms survival, but does not attribute low selection efficiency to their short lifespan. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
The use of an RNP complex is associated with reduced experimental time because the pre-assembled complex starts cutting immediately without waiting for plasmid transcription and translation.
“Moreover, the use of an RNP complex is associated with reduced experimental time, as the pre‐assembled complex is introduced into the cell nucleus and starts cutting immediately, without having to wait for the plasmid to be transcribed and the Cas9 protein to be translated (Kim et al., 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Kim et al., 2014 source
- Premisecitation
Constitutive expression of Cas9 and gRNA from lentiviral vectors increases the risk of off-target effects.
“Moreover, the constitutive expression of both Cas9 protein and gRNA increases the risk of off‐target effects (Lino et al., 2018; Papapetrou & Schambach, 2016).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Lino et al., 2018 source
The “Lentivirus (LV) and adenovirus (AdV)” section (page unavailable) says viral-payload integration can increase expression and off-target effects. The “Cas9 activity” section (page unavailable) also links excessive sgRNA to off-target effects. Neither passage specifically says that constitutive expression of both Cas9 and gRNA is what increases the risk. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites Papapetrou & Schambach, 2016 source
The genomic safe harbors section discusses risks from lentiviral vector integration, including disruption of nearby genes, but not off-target effects caused by constitutive Cas9 and gRNA expression. The section on targeting predetermined safe harbors names CRISPR-Cas9 as a targeting tool without addressing that risk. Searches for constitutive Cas9/gRNA expression and prolonged expression causing off-target cleavage found no supporting passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingown data
This protocol has been tested on HKs cultured in EpiLife Medium with no differences in genome editing efficiency compared to culture on feeder cells.
“However, this protocol has also been tested on HKs cultured in EpiLife Medium (Gibco, MEPI500CA) with no differences in genome editing efficiency.”
Quote in the paperNot a substantial claim - Findingown data
The best efficiency/survival ratio for primary human keratinocytes was achieved using the DS138 nucleofection program.
“We found that the best efficiency/survival ratio for primary HKs was achieved using the DS138 program.”
Quote in the paperSubstantial claim
- Findingown data
Nucleofection of Cas9/sgRNA ribonucleoprotein complexes efficiently generates deletion of specific genomic regions in primary human keratinocytes.
“By nucleofecting ribonucleoprotein complexes, we efficiently generate KO cells as well as deletion of specific genomic regions.”
- Also stated in: § DELETION OF SPECIFIC GENOMIC REGION USING RNPs VIA NUCLEOFECTION · plain
“This method allows up to 90% of targeted genomic deletion in primary HKs in only 3 days without clonal selection.”
- Also stated in: § DELETION OF SPECIFIC GENOMIC REGION USING RNPs VIA NUCLEOFECTION · boosted
“Representative DNA agarose gel showing efficient deletion of a DNA segment in primary HKs transfected with two Cas9/sgRNA RNP complexes (EDITED) compared to Cas9 protein only (CTR).”
Quote in the paperSubstantial claim - Also stated in: § DELETION OF SPECIFIC GENOMIC REGION USING RNPs VIA NUCLEOFECTION · plain
- Findingown data
Nucleofection and plating of 1 × 10^5 cells in one well of a 24-well plate or 2 × 10^5 cells in a 12-well plate did not cause loss of cell viability.
“We have nucleofected and plated 1 × 105cells in one well of a 24‐well plate or plated 2 × 105 cells in a 12‐well plate (Corning, 3513) without loss of cell viability.”
Quote in the paperSubstantial claim - Findingown data
Using sgRNA1+sgRNA2+Cas9 results in less efficient deletion of the region of interest than using two independent RNP complexes.
“In fact, in the first case, despite the reduction in cost by using a smaller amount of Cas9 protein, we found less efficient deletion of the region of interest, probably due to competition between sgRNAs for the Cas9 protein.”
Quote in the paperSubstantial claim - Findingown data
Nucleofection of Cas9/sgRNA ribonucleoprotein complexes efficiently generates gene knock-out cells in primary human keratinocytes.
“By nucleofecting ribonucleoprotein complexes, we efficiently generate KO cells as well as deletion of specific genomic regions.”
- Also stated in: § KNOCK‐OUT GENERATION BY INDEL MUTATION IN PRIMARY HUMAN KERATINOCYTES USING NUCLEOFECTION OF RIBONUCLEOPROTEIN (RNP) COMPLEX · plain
“To achieve high CRISPR/Cas9 genome editing efficiency (>90%) in a small number of HKs without clonal selection of the targeted cells, this protocol employs transient nucleofection of an RNP complex consisting of Cas9 protein and sgRNA containing chemical modifications to stabilize the RNA and increase its resistance to nuclease activity.”
Quote in the paperSubstantial claim - Also stated in: § KNOCK‐OUT GENERATION BY INDEL MUTATION IN PRIMARY HUMAN KERATINOCYTES USING NUCLEOFECTION OF RIBONUCLEOPROTEIN (RNP) COMPLEX · plain
- Findingreasoning
Using an immortalized HK cell line (N/TERT2G), a pre-screening approach was set up to sub-select potential mutant clones by designing an HDR donor oligo carrying a restriction site sequence that results in a silent mutation.
“Using an immortalized HK cell line (N/TERT2G), we set up a pre‐screening approach to preliminary sub‐select potential mutant clones by designing an HDR donor oligo carrying a restriction site sequence that results in a silent mutation.”
Quote in the paperSubstantial claim - Findingown data
For the squamous cell carcinoma cell line SCC13, the ED138 nucleofection program could improve nucleofection efficiency without excessively affecting cell viability.
“However, we noticed that for other epithelial cell lines, in particular the squamous cell carcinoma cell line SCC13 (Rheinwald & Beckett, 1981), the program ED138 could be used to improve nucleofection efficiency without excessively affecting cell viability.”
Quote in the paperNot a substantial claim - Findingown data
Using two independent RNP complexes formed by sgRNA1+Cas9 and sgRNA2+Cas9 provides the highest editing efficiency for deletion of a specific genomic region.
“We found that using two independent RNP complexes formed by sgRNA1+Cas9 and sgRNA2+Cas9 provides the highest editing efficiency.”
Quote in the paperSubstantial claim - Findingown data
Doubling the amount of Cas9 protein (sgRNA1+sgRNA2+2XCas9) still results in inefficient deletion of the region of interest.
“In the second case, despite doubling the amount of Cas9 protein that could theoretically bind the sgRNAs with the same efficiency, we still found an inefficient deletion of the region of interest.”
Quote in the paperSubstantial claim - Findingreasoning
PCR for the genomic region of interest, followed by enzymatic digestion and agarose gel electrophoresis, allows simple and clear pre-selection of putative genome-edited clones.
“PCR for the genomic region of interest, followed by enzymatic digestion and agarose gel electrophoresis, allows simple and clear pre‐selection of putative genome‐edited clones.”
Quote in the paperSubstantial claim - Findingnone given
Control cells nucleofected with Cas9 protein alone produce a clean PCR band corresponding to the amplicon containing the sequence of interest.
“Control cells that were uniquely nucleofected with Cas9 protein produce a clean band corresponding to the PCR amplicon containing the sequence of interest.”
Quote in the paperNot a substantial claim - Findingown data
The protocol achieves 50% to 60% efficiency of the desired modification.
“With this protocol, we have achieved 50% to 60% efficiency of the desired modification.”
Quote in the paperNot a substantial claim - Findingown data
No significant differences in editing efficiency or survival are observed between positive and negative strands of Alt-R HDR Donor Oligos.
“We observed no significant differences in efficiency or survival between positive and negative strands of Alt‐R™ HDR Donor Oligos.”
Quote in the paperNot a substantial claim - Findingreasoning
Control cells nucleofected with Cas9 protein alone retain high expression of the protein of interest.
“As expected, the control cells still have a high expression level of the protein of interest, as Cas9 could not proceed with the cut without the gRNA.”
Quote in the paperNot a substantial claim - Findingreasoning
CRISPR/Cas9 bulk targeted cells show very low levels of the protein of interest.
“On the other hand, CRISPR/Cas9 bulk targeted cells show very low levels of the protein of interest.”
Quote in the paperSubstantial claim - Findingnone given
Comparable genome editing efficiency is achieved using both 1 × 10^5 and 2 × 10^5 cells without scaling up Cas9 and sgRNA volumes.
“We were able to achieve comparable genome editing efficiency using both 1 × 105 and 2 × 105 cells without scaling up Cas9 and sgRNA volumes.”
Quote in the paperNot a substantial claim - Findingnone given
The protocol achieves nucleotide substitution with impressive efficiency compared to previous technologies.
“Although the mechanism of HDR is statistically less efficient than NHEJ, this protocol outlines an optimized method to achieve nucleotide substitution with impressive efficiency as compared to previous technologies.”
Quote in the paperNot a substantial claim- Rests on an assumption: HDR is statistically less efficient than NHEJ.
- Interpretationreasoning
This pre-screening method reduces the number of clones undergoing DNA sequencing.
“This method reduces the number of clones undergoing DNA sequencing.”
Quote in the paperSubstantial claim - Interpretationreasoning
Competition between sgRNAs for the Cas9 protein probably explains the reduced deletion efficiency when sgRNA1+sgRNA2+Cas9 is used.
“In fact, in the first case, despite the reduction in cost by using a smaller amount of Cas9 protein, we found less efficient deletion of the region of interest, probably due to competition between sgRNAs for the Cas9 protein.”
Quote in the paperSubstantial claim - Interpretationnone given
The described protocol can be applied for KO generation in N/TERT2G or in cancer cell lines of epithelial origin (such as SCC13, SCC12, or A431).
“The described protocol can be also applied for KO generation in N/TERT2G (Dickson et al., 2000) or in cancer cell lines of epithelial origin (such as SCC13, SCC12, or A431).”
Quote in the paperNot a substantial claim - Premisecitation
Nucleofection is the most efficient non-viral transfection approach for primary cells.
“nucleofection has been reported as the most efficient non‐viral transfection approach for primary cells (Aluigi et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Aluigi et al., 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The presence of a band corresponding to the control band in RNP-treated cells is probably due to the absence of a selection method to isolate edited cells.
“Again, the presence of a band corresponding to the control band is probably due to the fact that no selection method was used to isolate the edited cells.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A single-clone selection step is essential to identify clones carrying the mutation of interest.
“However, a single‐clone selection step is essential to identify the clones carrying the mutation of interest.”
Quote in the paperSubstantial claim - Interpretationnone given
The protocols described can be adopted in different laboratories to manipulate human keratinocytes with high efficiency.
“The protocols described here can be adopted in different laboratories to manipulate HKs with high efficiency.”
Quote in the paperSubstantial claim - Interpretationnone given
The described methods require small volumes of reagents.
“The main advantages of the methods described here are the high efficiency, the reduced number of cells used for each reaction, and the small volume of reagents needed, which improve the cost‐efficiency ratio.”
Quote in the paperSubstantial claim - Interpretationreasoning
The described methods improve the cost-efficiency ratio.
“The main advantages of the methods described here are the high efficiency, the reduced number of cells used for each reaction, and the small volume of reagents needed, which improve the cost‐efficiency ratio.”
Quote in the paperSubstantial claim - Interpretationown data
The described methods have high efficiency as a main advantage.
“The main advantages of the methods described here are the high efficiency, the reduced number of cells used for each reaction, and the small volume of reagents needed, which improve the cost‐efficiency ratio.”
Quote in the paperSubstantial claim - Interpretationown data
The described methods use a reduced number of cells per reaction.
“The main advantages of the methods described here are the high efficiency, the reduced number of cells used for each reaction, and the small volume of reagents needed, which improve the cost‐efficiency ratio.”
Quote in the paperSubstantial claim - Interpretationreasoning
The higher band intensity of the shorter amplicon with the deletion compared to the control band indicates highly efficient genomic deletion.
“The higher band intensity of the shorter amplicon with the deletion compared to the control band indicates a highly efficient genomic deletion.”
Quote in the paperSubstantial claim - Interpretationreasoning
Single-clone isolation is required for site-specific mutagenesis experiments.
“For this reason, single‐clone isolation is required for site‐specific mutagenesis experiments.”
Quote in the paperSubstantial claim - Interpretationreasoning
The faint band corresponding to the desired molecular weight in bulk targeted cells is due to the absence of a selection method to isolate edited cells.
“The presence of a faint band corresponding to the desired molecular weight is due to the fact that no selection method was used to isolate the edited cells.”
Quote in the paperNot a substantial claim
- May combine two claims. 12
- Classified as probably not a substantial claim. 13
May combine two claims.
PremisecitationThe Cas9 RNP complex is active for 24 to 48 hr, whereas plasmids remain active for several days.
“With this system, the nuclease is active for 24 to 48 hr, whereas plasmids remain active for several days, increasing the probability of cutting in regions other than the targeted one.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Kim et al., 2014 source
The Results section, “Kinetics of RGEN RNP-mediated genome editing” (page unavailable), reports that RNP-induced mutations plateaued after one day, directly delivered Cas9 was barely detectable at 24 hours, and plasmid-expressed Cas9 persisted for several days. It also links continued expression to accumulating off-target mutations. It does not establish that the RNP remains active for 24–48 hours; the 48-hour endpoint in another Results assay is a measurement time, not evidence of activity lasting that long. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisereasoningThe RNP complex method results in fewer off-target effects and faster editing compared to plasmid-expressing Cas9/sgRNA.
“Indeed, the RNP complex method results in fewer off‐target effects and faster editing.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Kim et al., 2014 source
May combine two claims.
PremisecitationNHEJ repairs double-strand breaks and infrequently results in insertions or deletions that can disrupt gene function.
“NHEJ operates by recognizing DSBs, processing the DNA ends, and ligating them, infrequently resulting in insertions or deletions (indels) that can disrupt gene function (Stinson & Loparo, 2021; Takata et al., 1998).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Stinson & Loparo, 2021 source
- cites Takata et al., 1998 source
The Introduction describes NHEJ as joining the ends of a double-strand break and says the resulting junctions can vary in sequence composition. It also identifies Ku and DNA ligase IV as NHEJ components. Our copy does not establish that insertions or deletions occur infrequently, that they disrupt gene function, or the claimed sequence of end-processing steps. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationHDR repairs double-strand breaks using a sister chromatid as a repair template and is considered an error-free system.
“Alternatively, the HDR pathway is capable of repairing DSBs using a sister chromatid as a repair template, and for this reason, it is considered an error‐free system.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Liang et al., 1998 source
The Discussion says sister chromatids can provide a homologous repair template. But the paper does not characterize HDR as uniformly error-free: the Abstract distinguishes conservative gene conversion from nonconservative repair and reports deletional homologous repair products. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataNo differences in cell viability and mutagenesis efficiency were observed in HKs using positive versus negative HDR donor oligos.
“In our experience, we observed no differences regarding cell viability and mutagenesis efficiency in HKs using positive and negative HDR donor oligos.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenGene editing in primary human keratinocytes is usually completed within 72 hr following RNP nucleofection.
“Gene editing in primary HKs is usually completed within 72 hr following RNP nucleofection.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenCell survival is usually highest if cells are kept more dense after nucleofection and not sparsely plated.
“Cell survival is usually highest if cells are kept more dense after nucleofection and not sparsely plated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEditing of 1 × 10^5 primary human keratinocytes was successfully tested without changing the proportion of reagents used.
“We successfully tested editing of 1 × 105 cells without changing the proportion of the reagents used.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPlating 50 cells per 100-mm plate guarantees single clone formation while avoiding cross-contamination between different clones.
“We found that 50 cells per 100‐mm plate guarantees single clone formation while avoiding cross‐contamination between different clones.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn general, editing efficiencies >80% are observed for both knockout and genomic deletion experiments, although efficiency may vary depending on the protein of interest.
“In general, we observe editing efficiencies >80% for both KO and genomic deletion experiments, although the efficiency might vary depending on the protein of interest.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCells nucleofected with RNP1+RNP2 show efficient deletion of a DNA segment, producing a shorter amplicon.
“Accordingly, the cells nucleofected with RNPs (RNP1+RNP2) show efficient deletion of a DNA segment (shorter amplicon).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe nucleofector delivers DNA directly into the nucleus, making nucleofection independent of cell division.
“the nucleofector allows DNA to be delivered directly into the nucleus, making nucleofection independent of cell division (Distler et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Distler et al., 2005 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSpCas9 requires the 'NGG' PAM sequence, which is commonly found in genomes, enabling CRISPR/Cas9 use in a wide range of species.
“SpCas9 requires “NGG” as a PAM sequence, which is commonly found in the genomes of most organisms, enabling the use of CRISPR/Cas9 technology in a wide range of species (Jiang & Doudna, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jiang & Doudna, 2017 source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThese methods can also be applied to other immortalized cells and tumoral cells of epithelial origin.
“These methods can also be applied to other immortalized cells and tumoral cells of epithelial origin.”
- Also stated in: § INTRODUCTION · plain
“These approaches have been successfully used with primary HKs and cell lines of epithelial origin; however, these methods can be easily adapted to other primary or immortalized cell types.”
Quote in the paperNot a substantial claim- Also stated in: § INTRODUCTION · plain
Classified as probably not a substantial claim.
InterpretationreasoningIncubating cells for 72 hr before clonal selection avoids increased cell mortality from immediate dilution.
“To avoid this issue, we incubate the cells for 72 hr before proceeding with clonal selection.”
Quote in the paperSubstantial claim- Rests on an assumption: Dilution of cells immediately after nucleofection increases cell mortality.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningDividing each nucleofection reaction and control reaction mix into two wells allows simultaneous analysis of the bulk population and the single-clone screen.
“Dividing each Nucleofection Reaction and Control Reaction mix into two wells allows simultaneous analysis of the bulk population (from one edited well) and the single‐clone screen (from the other well).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningA higher number of feeder cells is required to sustain single-cell expansion because some mitotically blocked 3T3-J2 cells undergo cell death over the extended period required for keratinocyte clones to grow (~15 days).
“A higher number of feeder cells is required to sustain single‐cell expansion. This is because, over the extended period required for keratinocyte clones to grow, which takes ∼15 days, some mitotically blocked 3T3‐J2 cells undergo cell death.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe time at which loss of protein expression will be observed depends on the half-life of the protein.
“The time at which loss of protein expression will be observed depends on the half‐life of the protein.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenThe optimized protocol reduces cell mortality associated with the editing/single-cloning process and rapidly evaluates genome editing efficiency.
“We optimized a protocol to reduce cell mortality associated with the editing/single‐cloning process and rapidly evaluate the efficiency of genome editing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenThese techniques may also be applied to other cell lines of epithelial origin.
“These techniques may also be applied to other cell lines of epithelial origin.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningDNA sequencing of positively digested clones is an essential step to verify insertion of the desired modifications.
“The enzymatic digestion screening is an efficient method to reduce time and cost, but DNA sequencing of positively digested clones is an essential step to verify insertion of the desired modifications.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenEnzymatic digestion screening is an efficient method to reduce time and cost.
“The enzymatic digestion screening is an efficient method to reduce time and cost, but DNA sequencing of positively digested clones is an essential step to verify insertion of the desired modifications.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The addition of Alt-R Cas9 Electroporation Enhancer to the Nucleofection Solution mix increases delivery efficiency.
“The addition of Alt‐R™ Cas9 Electroporation Enhancer to the Nucleofection Solution mix increases delivery efficiency.”
The paper relies on this without support.
Specific inserts in the 1- to 2-kb range can be introduced efficiently using homology arms of 200 to 300 bp in length; for shorter insertions, homology arms of 30 to 60 nt can be used.
“Specific inserts in the 1‐ to 2‐kb range can be introduced efficiently using homology arms of 200 to 300 bp in length. For insertions of shorter length, shorter homology arms of 30 to 60 nt can be used.”
The paper relies on this without support.
HDR-mediated genome editing requires a single-clone selection step to obtain a homogeneous population.
“HDR‐mediated genome editing requires a single‐clone selection step to obtain a homogeneous population that will be further screened by DNA sequencing.”
The paper relies on this without support.
The identification of clones having the modification of interest can be time-consuming and requires several cell doublings.
“However, the identification of clones having the modification of interest can be a time‐consuming step and will require several cell doublings.”
The paper relies on this without support.
The efficiency of CRISPR/Cas9-mediated genome editing can be affected by the delivery system used.
“The efficiency of CRISPR/Cas9‐mediated genome editing can also be affected by the delivery system used.”
The paper relies on this without support.
Nucleofection is a highly efficient technology used to easily achieve delivery of RNP.
“Nucleofection is a highly efficient technology used to easily achieve delivery of RNP.”
The paper relies on this without support.
Primary cells maintained in vitro, including HKs, have a short lifespan with a limited number of cell divisions before undergoing senescence, even when cultured on feeder cells.
“One of the main reasons is related to the fact that primary cells maintained in vitro, including HKs, have a short lifespan with a limited number of cell divisions before undergoing senescence, even when cultured on feeder cells, thus reducing the possibility of long‐term clonal selection after gene editing.”
The paper relies on this without support.
HKs are notoriously refractory to genetic manipulation with conventional methods.
“Moreover, HKs are notoriously refractory to genetic manipulation with conventional methods.”
The paper relies on this without support.
Lipid-based transfection consistently shows low efficiency of DNA uptake and expression.
“For example, lipid‐based transfection consistently shows low efficiency of DNA uptake and expression.”
The paper relies on this without support.
Culture of HKs on feeder cells is a key step for providing a supportive environment to promote cell growth and maintain an undifferentiated state.
“Culture of HKs on feeder cells is a key step for providing a supportive environment to promote cell growth and maintain an undifferentiated state.”
The paper relies on this without support.
The addition of silent mutations in the PAM sequence prevents Cas9-mediated re-cutting after donor incorporation.
“The addition of silent mutations in the PAM sequence is highly recommended to prevent Cas9‐mediated re‐cutting after donor incorporation.”
The paper relies on this without support.
Long-term exposure to Nucleofection Solution mix might be toxic for the cells.
“Long‐term exposure to Nucleofection Solution mix might be toxic for the cells.”
The paper relies on this without support.
The Alt-R Cas9 Electroporation Enhancer can be toxic to the cells.
“especially the Alt‐R™ Cas9 Electroporation Enhancer, which can be toxic to the cells.”
The paper relies on this without support.
Dilution of cells immediately after nucleofection increases cell mortality.
“However, dilution of cells immediately after nucleofection increases cell mortality.”
The paper relies on this without support.
A higher volume than 35 µl in the nucleocuvette can severely reduce nucleofection efficiency.
“Do not exceed a final volume of Nucleofection Solution mix of 35 µl; in fact, a higher volume in the strip could severely reduce nucleofection efficiency.”
The paper relies on this without support.
Long-term exposure to Nucleofection Solution mix might be toxic for cells.
“Long‐term exposure to Nucleofection Solution mix might be toxic for the cells. Therefore, avoid leaving cells in Nucleofection Solution mix for >30 min.”
The paper relies on this without support.
Alt-R Cas9 Electroporation Enhancer can be toxic for cells.
“The following day, exchange the keratinocyte growth medium with fresh medium to remove the Nucleofection Reaction mix, and particularly the Alt‐R™ Cas9 Electroporation Enhancer, which can be toxic for the cells.”
The paper relies on this without support.
The addition of ROCK inhibitor Y27632 is essential to extend the lifespan of human keratinocytes.
“The addition of the ROCK inhibitor Y27632 (Enzo Life Sciences, EN270333M005) is essential to extend the lifespan of HKs.”
The paper relies on this without support.
HDR is statistically less efficient than NHEJ.
“Although the mechanism of HDR is statistically less efficient than NHEJ, this protocol outlines an optimized method to achieve nucleotide substitution with impressive efficiency as compared to previous technologies.”
The paper relies on this without support.
For knockout generation, the CRISPR/Cas9 system exploits the NHEJ repair mechanism.
“Whereas for KO generation (Basic Protocol 2), the CRISPR/Cas9 system exploits the NHEJ repair mechanism, mutagenesis with a precise modification at a specific location in the genome requires the use of a donor oligo DNA to favor the HDR mechanism.”
The paper relies on this without support.
Mutagenesis with a precise modification at a specific genomic location requires a donor oligo DNA to favor the HDR mechanism.
“Whereas for KO generation (Basic Protocol 2), the CRISPR/Cas9 system exploits the NHEJ repair mechanism, mutagenesis with a precise modification at a specific location in the genome requires the use of a donor oligo DNA to favor the HDR mechanism.”
The paper relies on this without support.
The HDR machinery uses the donor template to accurately repair Cas9-mediated double-strand breaks, incorporating the desired genetic modifications into the genome.
“The HDR machinery uses the donor template to accurately repair the DSBs mediated by the Cas9 protein, incorporating the desired genetic modifications into the genome.”
The paper relies on this without support.
HDR can be used to introduce a wide range of genetic modifications, such as point mutations and gene insertion or correction.
“HDR can be used to introduce a wide range of genetic modifications, such as point mutations and gene insertion or correction.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Day 3 collection conflicts with the 72-hour post-nucleofection instruction
MajorThe schedule places nucleofection on Day 1 and collection on Day 3, only two days later. The protocols instruct harvesting or analyzing cells at least 72 hours after nucleofection.
“‐ Day 1: preparation of reagents and CRISPR/Cas9 RNP nucleofection‐ Day 2: incubation of cells to allow CRISPR/Cas9 editing to occur‐ Day 3: collection of cells and preparation of samples for further analysis.”
“Harvest and analyze cells ≥72 hr post‐nucleofection.”
Knockout generation is assigned to the wrong protocol
MinorThe HDR protocol identifies Basic Protocol 2 as the knockout protocol, but the paper labels Basic Protocol 1 as knockout generation and Basic Protocol 2 as genomic deletion.
“Whereas for KO generation (Basic Protocol 2), the CRISPR/Cas9 system exploits the NHEJ repair mechanism”
“Basic Protocol 1: Knock‐out generation by indel mutation in primary human keratinocytes using nucleofection of ribonucleoprotein (RNP) complex”
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133 · see citing works
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 6,304 · see citing works
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741 · see citing works
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429 · see citing works
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Concordet, J., & Haeussler, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky354 · Cited by 2,354 · see citing works
CRISPR–Cas9 Structures and Mechanisms
Jiang, F., & Doudna, J. A. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062215-010822 · Cited by 2,029 · see citing works
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856 · see citing works
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo
Moreno-Mateos, M. A., Vejnar, C. E., Beaudoin, J.-D., Fernandez, J. P., Mis, E. K., Khokha, M. K., & Giraldez, A. J. (2015) · Nature Methods · doi:10.1038/nmeth.3543 · Cited by 1,290 · see citing works
Takata, M., Sasaki, M. S., Sonoda, E., Morrison, C., Hashimoto, M., Utsumi, H., Yamaguchi‐Iwai, Y., Shinohara, A., & Takeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5497 · Cited by 1,229 · see citing works
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185 · see citing works
Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma
Rheinwald, J. G., & Green, H. (1975) · Cell · doi:10.1016/0092-8674(75)90183-x · Cited by 1,122 · see citing works
Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104 · see citing works
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering
Labun, K., Montague, T. G., Gagnon, J. A., Thyme, S. B., & Valen, E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw398 · Cited by 910 · see citing works
Rheinwald, J. G., & Beckett, M. A. (1981) · PubMed · Cited by 759 · see citing works
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649 · see citing works
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431 · see citing works
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
Chylinski, K., Rhun, A. L., & Charpentier, E. (2013) · RNA Biology · doi:10.4161/rna.24321 · Cited by 369 · see citing works
Mechanism of DNA double-strand break repair by non-homologous end joining
Hefferin, M. L., & Tomkinson, A. E. (2005) · DNA repair · doi:10.1016/j.dnarep.2004.12.005 · Cited by 319 · see citing works
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Papapetrou, E. P., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.38 · Cited by 238 · see citing works
Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks
Paix, A., Folkmann, A. W., Goldman, D. H., Kulaga, H. M., Grzelak, M. J., Rasoloson, D., Paidemarry, S., Green, R., Reed, R. R., & Seydoux, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711979114 · Cited by 229 · see citing works
Repair of DNA Double-Strand Breaks by the Nonhomologous End Joining Pathway
Stinson, B. M., & Loparo, J. J. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-080320-110356 · Cited by 223 · see citing works
Aluigi, M., Fogli, M., Curti, A., Isidori, A., Gruppioni, E., Chiodoni, C., Colombo, M., Versura, P., D'Errico-Grigioni, A., Ferri, E., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0198 · Cited by 166 · see citing works
Dong, W., & Kantor, B. (2021) · Viruses · doi:10.3390/v13071288 · Cited by 153 · see citing works
Fenini, G., Grossi, S., Contassot, E., Biedermann, T., Reichmann, E., French, L. E., & Beer, H.-D. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.016 · Cited by 125 · see citing works
Nucleofection: a new, highly efficient transfection method for primary human keratinocytes*
Distler, J. H. W., Jüngel, A., Kurowska‐Stolarska, M., Michel, B. A., Gay, R. E., Gay, S., & Distler, O. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00276.x · Cited by 53 · see citing works
Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G
Mestrallet, G., Rouas‐Freiss, N., LeMaoult, J., Fortunel, N. O., & Martin, M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772516 · Cited by 44 · see citing works
Strategies for precise gene edits in mammalian cells
Fichter, K. M., Setayesh, T., & Malik, P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.012 · Cited by 34 · see citing works
CRISPR /Cas9 gene editing special issue
Doench, J. G. (2016) · FEBS Journal · doi:10.1111/febs.13823 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Viral genome editing methods and applications in the CRISPR era
Shin, K., & Kim, E. T. (2026) · Journal of Virology · doi:10.1128/jvi.02048-25 · Cited by 3 · see citing works
Papillomavirus-like particles as vectors for ex vivo gene therapy of the skin
Diversi, F., Dabin, J., Mazza, E., Rinaldin, M., Reis, F. D. C., Hackett, J. A., & Heppenstall, P. A. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102501 · Cited by 2 · see citing works
“47 Moreover, nucleoporation is inherently restricted ex vivo and cannot be applied for in vivo therapy.”
Therapeutic p63 isoform switching rescues epidermal defects in AEC syndrome
Girolamo, D. D., Urciuoli, G., Sol, S., Ferniani, M., Antonini, D., Marchese, E., Palumbo, S., Stefano, M. A. D., Baltissen, M. P. A., Ros, M. A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.045
Self-citationKlijnhout, J. A., Senders, E., van den Bogaard, E. H. J., et al. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5253-4_7
- Authors
- Bamundo, M., Palumbo, S., D'Auria, L., Missero, C., & Di Girolamo, D.
- Affiliations
- University of Milan (IT)
- CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT)
- CEINGE Biotecnologie Avanzate Franco Salvatore Naples Italy
- Venue
- Current Protocols
- Publisher
- Wiley
- Published
- 2024-11
- Volume
- 4
- Issue
- 11
- Pages
- e70056-e70056
- ISSN
- 2691-1299 (ISSN-L)
- PMC
- PMC11600394
- OpenAlex
- W4404765956
- Cited by
- 4
- References
- 30
- Citations by year
- 2026: 2 · 2025: 2
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Current Protocols (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, primary human keratinocytes, gene knockout, genomic deletions, homology-directed repair, site-directed mutagenesis, immortalized keratinocytes, skin diseases, 3D skin model, transfection efficiency
- MeSH terms
- Gene Editing, Cells, Cultured, Humans, Ribonucleoproteins, Transfection, Keratinocytes, Mutagenesis, Gene Knockout Techniques, Recombinational DNA Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review